Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Quisinostat |
| Trade Name | |
| Synonyms | JNJ-26481585|JNJ-6481585 |
| Drug Descriptions |
Quisinostat (JNJ-26481585) is a second-generation HDAC inhibitor, which increases histone acetlyation, and may increase tumor cell apoptosis and inhibit tumor growth (PMID: 24038993, PMID: 19861438, PMID: 31784862). |
| DrugClasses | HDAC Inhibitor 45 |
| CAS Registry Number | 875320-29-9 |
| NCIT ID | C77912 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Erdafitinib + Quisinostat | Erdafitinib Quisinostat | 1 | 0 |
| Palbociclib + Quisinostat | Palbociclib Quisinostat | 0 | 0 |
| Pemigatinib + Quisinostat | Pemigatinib Quisinostat | 0 | 0 |
| Quisinostat | Quisinostat | 0 | 2 |